Page 31 - 775 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at—risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo — or dummy pill — later died of covid, but there were no dea...

Hospitalisations by death might have. , ., , ., have. the news of the efficacy of this particular — have. the news of the efficacy of this particular antiviral _ have. the news of the efficacy of this particular antiviral is - this particular antiviral is obviously particularly good news was at the company, when they briefed us last night had they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated elderly or medically at risk volunteers within five days of them showing corona virus symptoms. the data from a phase three trial sho...

Approval by young people. i am joined by dr. peter hotez, he is also the dean at bail lor college of medicine. thank you for joining us. i want to ask you first, you know i've always been suspicious of vaccines or drugs when they come from drug companies particularly publicly traded drug companies and i like to hear this from experts like you. it's got a drug. >> it's a small study, it's 775 individuals with covid, half who got the pills, half who did not, but there was a pretty striking reduction in hospitalizations, 14% versus 7% and here's the extra piece and there were eight deaths in the ...

Medication for covid—19. mark lobel reports. this is the first covid pill. trial results suggest it can cut hospitalisations or deaths by half. the news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated, elderly or medically at risk volunteers within five days of them showing coronaviruses symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised,...

Is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at—risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo — or dummy pill — later died of covid, but there were no deaths in the group taking the pill. the trial was stoppe...